RCVRN

gene
On this page

Summary

RCVRN (recoverin, HGNC:9937) is a protein-coding gene on chromosome 17p13.1, encoding Recoverin (P35243). Acts as a calcium sensor and regulates phototransduction of cone and rod photoreceptor cells.

This gene encodes a member of the recoverin family of neuronal calcium sensors. The encoded protein contains three calcium-binding EF-hand domains and may prolong the termination of the phototransduction cascade in the retina by blocking the phosphorylation of photo-activated rhodopsin. Recoverin may be the antigen responsible for cancer-associated retinopathy.

Source: NCBI Gene 5957 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 23 total
  • MANE Select transcript: NM_002903

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:9937
Approved symbolRCVRN
Namerecoverin
Location17p13.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000109047
Ensembl biotypeprotein_coding
OMIM179618
Entrez5957

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000226193, ENST00000570909

RefSeq mRNA: 1 — MANE Select: NM_002903 NM_002903

CCDS: CCDS11151

Canonical transcript exons

ENST00000226193 — 3 exons

ExonStartEnd
ENSE0000068491899009899901100
ENSE0000085513999048009905271
ENSE0000129480398963209898204

Expression profiles

Bgee: expression breadth ubiquitous, 156 present calls, max score 78.13.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 5.6828 / max 2585.5624, expressed in 17 samples.

FANTOM5 promoters (7 alternative TSS)

Promoter IDTPM avgSamples expressed
1645115.459214
1645100.10728
1645060.04956
1645090.02995
1645120.01425
1645070.01154
1645080.01133

Top tissues by expression

290 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.13gold quality
type B pancreatic cellCL:000016973.33gold quality
olfactory bulbUBERON:000226473.30gold quality
retinaUBERON:000096671.70gold quality
pigmented layer of retinaUBERON:000178271.69gold quality
pineal bodyUBERON:000190568.17silver quality
cortical plateUBERON:000534368.03gold quality
endometrium epitheliumUBERON:000481167.67gold quality
right frontal lobeUBERON:000281066.10gold quality
cingulate cortexUBERON:000302765.53gold quality
anterior cingulate cortexUBERON:000983565.22gold quality
granulocyteCL:000009465.04gold quality
Brodmann (1909) area 9UBERON:001354064.67gold quality
diaphragmUBERON:000110363.03gold quality
thymusUBERON:000237062.89gold quality
dorsolateral prefrontal cortexUBERON:000983462.45gold quality
mononuclear cellCL:000084261.52gold quality
monocyteCL:000057661.47gold quality
leukocyteCL:000073861.25gold quality
neocortexUBERON:000195061.19gold quality
tongue squamous epitheliumUBERON:000691960.84gold quality
frontal cortexUBERON:000187060.71gold quality
omental fat padUBERON:001041460.57gold quality
peritoneumUBERON:000235860.56gold quality
left uterine tubeUBERON:000130360.34gold quality
Brodmann (1909) area 46UBERON:000648360.17gold quality
cerebral cortexUBERON:000095659.64gold quality
adipose tissue of abdominal regionUBERON:000780859.51gold quality
orbitofrontal cortexUBERON:000416759.50gold quality
vastus lateralisUBERON:000137959.48gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 4.

ExperimentMarker?Max mean expression
E-MTAB-7316yes11662.95
E-MTAB-11121yes7666.83
E-GEOD-137537yes4478.45
E-ANND-3no0.00

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): NR1D1, NR2E3, RBPJ

miRNA regulators (miRDB)

34 targeting RCVRN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-1343-3P99.8966.781815
HSA-MIR-6783-3P99.8967.922059
HSA-MIR-449299.8768.253611
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-149-3P99.7268.223963
HSA-MIR-6883-5P99.6968.053785
HSA-MIR-4666B99.6468.691282
HSA-MIR-715099.6266.801322
HSA-MIR-6797-5P99.6166.552084
HSA-MIR-1249-5P99.6166.552049
HSA-MIR-7106-5P99.5367.473574
HSA-MIR-1207-5P99.4969.112983
HSA-MIR-449899.4767.422360
HSA-MIR-6852-5P99.1766.692073
HSA-MIR-4763-3P99.1067.832649
HSA-MIR-465199.0667.572002
HSA-MIR-6506-5P99.0465.661386
HSA-MIR-939-3P98.9765.072347
HSA-MIR-60898.9367.832013
HSA-MIR-4764-5P98.8865.53894
HSA-MIR-6840-3P98.6865.951923
HSA-MIR-619-5P98.5764.971988
HSA-MIR-1022698.2566.50811
HSA-MIR-6742-3P97.9564.501490
HSA-MIR-6862-5P97.4864.84713
HSA-MIR-27B-5P97.3466.55549
HSA-MIR-313996.6866.77652
HSA-MIR-28-5P96.1666.12579

Literature-anchored findings (GeneRIF, showing 11)

  • recoverin has a pathological role in cancer-associated retinopathy (PMID:12596918)
  • There are cis-acting elements in the 5’ non-coding region of the recoverin gene that are involved in the activation and suppression of gene expression. (PMID:12789533)
  • Human recoverin is expressed in SCLC cells cultured from an anti-recoverin antibody-negative patient with CAR. KK0206 might be important for further research on SCLC related retinopathy. (PMID:17374419)
  • A GRK1 region close to its C-terminus also seemed to be the binding site for S-modulin/recoverin. (PMID:18266817)
  • Aberrant hypomethylation of the recoverin gene region, overlapping the promoter up-stream of the first exon and the first exon itself, is involved in the aberrant expression of recoverin in tumor cells. (PMID:20812967)
  • C39D substitution reduces alpha-helical content, decreases thermal stability and suppresses membrane association. (PMID:21344177)
  • Crystal Structure of Recoverin with Calcium Ions Bound to Both Functional EF Hands. (PMID:26584024)
  • High RCVRN expression is associated with renal tumors. (PMID:26813565)
  • these data confirm the scaffolding function of several cluster-forming residues and point to their critical role in supporting physiological activity of recoverin (PMID:31288444)
  • Recoverin (Rec) is a prototypical calcium sensor protein primarily expressed in the vertebrate retina. The binding of two Ca(2+) ions to the functional EF-hand motifs induces the extrusion of a myristoyl group that increases the affinity of Rec for the membrane and leads to the formation of a complex with rhodopsin kinase (GRK1). (PMID:31658639)
  • Serum anti-recoverin antibodies is found in elderly patients with retinitis pigmentosa and cancer. (PMID:32043815)

Cross-species orthologs

8 orthologs

OrganismSymbolGene ID
danio_reriorcvrn3ENSDARG00000009637
danio_reriorcvrn2ENSDARG00000019902
mus_musculusRcvrnENSMUSG00000020907
rattus_norvegicusRcvrnENSRNOG00000003633
drosophila_melanogasterCG7646FBGN0036926
drosophila_melanogasterCG5890FBGN0039380
caenorhabditis_elegansncs-2WBGENE00003564
caenorhabditis_elegansWBGENE00015867

Paralogs (14): CLXN (ENSG00000034239), GUCA1A (ENSG00000048545), NCALD (ENSG00000104490), NCS1 (ENSG00000107130), GUCA1B (ENSG00000112599), KCNIP3 (ENSG00000115041), HPCAL1 (ENSG00000115756), HPCAL4 (ENSG00000116983), KCNIP2 (ENSG00000120049), HPCA (ENSG00000121905), GUCA1C (ENSG00000138472), VSNL1 (ENSG00000163032), KCNIP1 (ENSG00000182132), KCNIP4 (ENSG00000185774)

Protein

Protein identifiers

RecoverinP35243 (reviewed: P35243)

Alternative names: Cancer-associated retinopathy protein

All UniProt accessions (1): P35243

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a calcium sensor and regulates phototransduction of cone and rod photoreceptor cells. Modulates light sensitivity of cone photoreceptor in dark and dim conditions. In response to high Ca(2+) levels induced by low light levels, prolongs RHO/rhodopsin activation in rod photoreceptor cells by binding to and inhibiting GRK1-mediated phosphorylation of RHO/rhodopsin. Plays a role in scotopic vision/enhances vision in dim light by enhancing signal transfer between rod photoreceptors and rod bipolar cells. Improves rod photoreceptor sensitivity in dim light and mediates response of rod photoreceptors to facilitate detection of change and motion in bright light.

Subunit / interactions. Homodimer; disulfide-linked. Homodimerization is caused by prolonged intense illumination. May form a complex composed of RHO, GRK1 and RCVRN in a Ca(2+)-dependent manner; RCVRN prevents the interaction between GRK1 and RHO. Interacts (via C-terminus) with GRK1 (via N-terminus); the interaction is Ca(2+)-dependent.

Subcellular location. Photoreceptor inner segment. Cell projection. Cilium. Photoreceptor outer segment. Photoreceptor outer segment membrane. Perikaryon.

Tissue specificity. Retina and pineal gland.

Post-translational modifications. The N-terminal glycine is linked to one of four different types of acyl groups. The most abundant is myristoleate (14:1), but 14:0, 14:2, and 12:0 acyl residues are also present. The Ca(2+) induced exposure of the myristoyl group, known as the calcium-myristoyl switch, promotes RCVRN binding to the photoreceptor cell membranes only when intracellular Ca(2+) concentration is high. Oxidation on Cys-39 occurs in response to prolonged intense illumination and results in the formation of disulfide homodimers, and to a lesser extent disulfide-linked heterodimers.

Domain organisation. EF-hand 2 and EF-hand 3 domains are the low-affinity and the high-affinity calcium binding sites, respectively. EF-hand 1 and EF-hand 4 domains do not bind calcium due to substitutions that disrupt their respective Ca(2+) binding loops. The cooperative binding of calcium to the EF-hand 2 domain following EF-hand 3 domain calcium binding requires myristoylation. Calcium binding to the 2 EF-hand domains induces exposure of the myristoyl group through a protein conformation change, this process known as the calcium-myristoyl switch facilitates binding to photoreceptor cell membranes.

Similarity. Belongs to the recoverin family.

RefSeq proteins (1): NP_002894* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002048EF_hand_domDomain
IPR011992EF-hand-dom_pairHomologous_superfamily
IPR018247EF_Hand_1_Ca_BSBinding_site
IPR028846RecoverinFamily

Pfam: PF13499, PF13833

UniProt features (37 total): helix 11, binding site 10, domain 4, strand 4, initiator methionine 1, chain 1, site 1, modified residue 1, lipid moiety-binding region 1, disulfide bond 1, turn 1, region of interest 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
2D8NX-RAY DIFFRACTION2.2

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P35243-F184.110.38

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 192 (interaction with grk1)

Ligand- & substrate-binding residues (10): 80; 85; 110; 112; 114; 116; 121; 74; 76; 78

Post-translational modifications (2): 39, 2

Disulfide bonds (1): 39

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-2514859Inactivation, recovery and regulation of the phototransduction cascade

MSigDB gene sets: 108 (showing top): GOBP_PHOTOTRANSDUCTION, RIZKI_TUMOR_INVASIVENESS_3D_DN, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_RADIATION, GOBP_DETECTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, MODULE_88, GOBP_DETECTION_OF_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOCC_NEURON_PROJECTION, GOBP_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT, AGCTCCT_MIR28

GO Biological Process (5): signal transduction (GO:0007165), visual perception (GO:0007601), phototransduction (GO:0007602), regulation of signal transduction (GO:0009966), regulation of calcium ion transport (GO:0051924)

GO Molecular Function (3): calcium ion binding (GO:0005509), calcium sensitive guanylate cyclase activator activity (GO:0008048), metal ion binding (GO:0046872)

GO Cellular Component (6): photoreceptor outer segment (GO:0001750), photoreceptor inner segment (GO:0001917), dendrite (GO:0030425), perikaryon (GO:0043204), membrane (GO:0016020), cell projection (GO:0042995)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
The phototransduction cascade1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure5
signal transduction2
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
sensory perception of light stimulus1
detection of light stimulus1
regulation of cell communication1
regulation of signaling1
regulation of response to stimulus1
calcium ion transport1
regulation of metal ion transport1
metal ion binding1
guanylate cyclase activator activity1
cation binding1
photoreceptor cell cilium1
neuron projection1
dendritic tree1
neuronal cell body1

Protein interactions and networks

STRING

2320 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RCVRNGRK7Q8WTQ7955
RCVRNRHOP08100941
RCVRNGRK1Q15835938
RCVRNCRXO43186907
RCVRNGUCY2DQ02846850
RCVRNSAGP10523832
RCVRNAMPHP49418819
RCVRNOTX2P32243805
RCVRNBIN1O00499782
RCVRNVSX2P58304782
RCVRNZIC4Q8N9L1763
RCVRNGAD2Q05329758
RCVRNKCNC1P48547756
RCVRNARR3P36575751
RCVRNPNMA2Q9UL42735

IntAct

13 interactions, top by confidence:

ABTypeScore
ASF1BHAT1psi-mi:“MI:0914”(association)0.640
RCVRNRAB9Apsi-mi:“MI:0914”(association)0.530
COMMD10VPS26Cpsi-mi:“MI:0914”(association)0.530
ARL4DIFI30psi-mi:“MI:0914”(association)0.530
CXXC4RCVRNpsi-mi:“MI:0915”(physical association)0.400
IL15RARCVRNpsi-mi:“MI:0915”(physical association)0.370
RCVRNSMAD3psi-mi:“MI:0915”(physical association)0.370
TGFBR2RCVRNpsi-mi:“MI:0915”(physical association)0.370
RCVRNGIT2psi-mi:“MI:0915”(physical association)0.370
ASF1BHAT1psi-mi:“MI:0914”(association)0.350
PQBP1RCVRNpsi-mi:“MI:0915”(physical association)0.000

BioGRID (22): SCRN3 (Affinity Capture-MS), RAB9A (Affinity Capture-MS), C11orf73 (Affinity Capture-MS), RCVRN (Affinity Capture-MS), RCVRN (Affinity Capture-MS), RCVRN (Reconstituted Complex), GRK5 (Affinity Capture-Western), GRK6 (Affinity Capture-Western), CAV1 (Affinity Capture-Western), SCRN3 (Affinity Capture-MS), RCVRN (Affinity Capture-MS), RCVRN (Affinity Capture-MS), RCVRN (Affinity Capture-MS), C11orf73 (Affinity Capture-MS), RAB9A (Affinity Capture-MS)

ESM2 similar proteins: G5EDN6, O73761, P0CM54, P0CM55, P21457, P22728, P25296, P28470, P29104, P34057, P35243, P35332, P42322, P43080, P43081, P46065, P48451, P61022, P61023, P62760, P62761, P62762, P62763, P62764, P63098, P63099, P63100, P79880, P87072, Q24214, Q2TBI5, Q4R5F7, Q54MF3, Q55G87, Q5R6S5, Q5R7F0, Q5RD22, Q63810, Q63811, Q6BWS8

Diamond homologs: A0JN54, A8JQ65, B3LXF2, B3NYS4, B4I4Y1, B4JHJ7, B4K6T8, B4PRE2, B4R0A5, D3YWQ0, D3ZEY4, F1MAB7, O08560, O75912, O88673, P0CM54, P0CM55, P20192, P23743, P25296, P34057, P34125, P35243, P49619, P49620, P49621, P51556, P52429, P52824, P87072, Q01583, Q03603, Q09103, Q10024, Q13574, Q39017, Q6BWS8, Q6CGE6, Q6DT37, Q6FLU4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

23 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance20
Likely benign0
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

369 predictions. Top by Δscore:

VariantEffectΔscore
17:9901002:T:Adonor_gain1.0000
17:9901013:T:TAdonor_gain1.0000
17:9901014:C:Adonor_gain1.0000
17:9901096:ATAGC:Aacceptor_gain1.0000
17:9901097:TAGC:Tacceptor_gain1.0000
17:9901098:AGC:Aacceptor_gain1.0000
17:9901098:AGCC:Aacceptor_loss1.0000
17:9901099:GC:Gacceptor_gain1.0000
17:9901100:CC:Cacceptor_gain1.0000
17:9901101:C:CCacceptor_gain1.0000
17:9901101:CT:Cacceptor_loss1.0000
17:9901102:T:Cacceptor_loss1.0000
17:9901103:G:Cacceptor_gain1.0000
17:9901107:C:CTacceptor_gain1.0000
17:9904796:TGAC:Tdonor_loss1.0000
17:9904797:GAC:Gdonor_loss1.0000
17:9904798:A:ACdonor_gain1.0000
17:9904798:ACC:Adonor_loss1.0000
17:9904799:C:CCdonor_gain1.0000
17:9904819:T:TAdonor_gain1.0000
17:9900891:G:Adonor_gain0.9900
17:9900984:TTCAC:Tdonor_loss0.9900
17:9900985:TCA:Tdonor_loss0.9900
17:9900986:CACC:Cdonor_loss0.9900
17:9900987:ACC:Adonor_loss0.9900
17:9900988:C:CAdonor_loss0.9900
17:9900988:CCAT:Cdonor_gain0.9900
17:9901010:A:ACdonor_gain0.9900
17:9901011:C:CCdonor_gain0.9900
17:9901103:G:GCacceptor_gain0.9900

AlphaMissense

1345 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:9898183:A:GF172S0.998
17:9901030:C:GR151P0.998
17:9904863:G:CF106L0.998
17:9904863:G:TF106L0.998
17:9904865:A:GF106L0.998
17:9904969:C:GR71P0.998
17:9904971:G:CF70L0.998
17:9904971:G:TF70L0.998
17:9904973:A:GF70L0.998
17:9904871:A:GW104R0.997
17:9904871:A:TW104R0.997
17:9904932:G:CF83L0.997
17:9904932:G:TF83L0.997
17:9904933:A:GF83S0.997
17:9904934:A:GF83L0.997
17:9905035:A:GF49S0.997
17:9905076:G:CF35L0.997
17:9905076:G:TF35L0.997
17:9905078:A:GF35L0.997
17:9898182:G:CF172L0.996
17:9898182:G:TF172L0.996
17:9898184:A:GF172L0.996
17:9901100:C:GA128P0.996
17:9904831:A:TI117N0.996
17:9904858:A:GL108P0.996
17:9904869:C:AW104C0.996
17:9904869:C:GW104C0.996
17:9904915:G:TA89D0.996
17:9904921:A:TV87D0.996
17:9904972:A:GF70S0.996

dbSNP variants (sampled 300 via entrez): RS1000581302 (17:9906782 G>A), RS1000697346 (17:9906988 C>T), RS1000783060 (17:9895837 A>T), RS1000838758 (17:9896368 T>A), RS1001053550 (17:9896032 G>A,C), RS1001353468 (17:9902147 C>G,T), RS1001546157 (17:9906235 A>C), RS1002200003 (17:9902600 G>T), RS1002258819 (17:9897230 T>C), RS1003045879 (17:9898281 A>G), RS1003183970 (17:9899799 T>A,C), RS1003210655 (17:9905528 T>C), RS1003382947 (17:9899361 A>G), RS1003505720 (17:9905377 G>A,C,T), RS1003854930 (17:9902506 C>A)

Disease associations

OMIM: gene MIM:179618 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

14 total (human), top 14 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects cotreatment, increases methylation, decreases expression3
tetrabromobisphenol Sdecreases expression1
tetrabromobisphenol Adecreases expression1
nickel sulfatedecreases expression1
2-palmitoylglycerolincreases expression1
bisphenol Saffects cotreatment, increases methylation1
theaflavin-3,3’-digallateaffects expression1
Fulvestrantaffects cotreatment, increases methylation1
Aluminumaffects binding, increases expression1
Benzo(a)pyrenedecreases methylation1
Formaldehydedecreases expression1
Potassium Chloridedecreases response to substance, increases expression1
Dronabinoldecreases response to substance, increases expression1
Aflatoxin B1increases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.